Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Raffel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Blood|July 20, 2022
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Christina Schmidt, Peter-Martin Bruch, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Blood Cancer Discovery|December 5, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic LeukemiaMark Hartmann, Maximilian Schönung, Jovana Rajak, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Blood|July 20, 2022
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Christina Schmidt, Peter-Martin Bruch, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Blood Cancer Discovery|December 5, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic LeukemiaMark Hartmann, Maximilian Schönung, Jovana Rajak, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Pageof 5